India Demonstrates Strong Market Potential with Rising Obesity Prevalence Revenue from obesity GLP-1 treatment in India is expanding at a CAGR of 28.4%, supported by increasing obesity rates in metropolitan areas and growing awareness of cardiovascular risk factors
We evaluated nine programs across pricing transparency, clinical rigor, medication breadth, coaching depth, and regulatory standing
Diabetologia 55: 2445-2455, 2012
IV therapy is ideal for anyone seeking immediate, personalized results to improve their well-being, whether for general wellness or specific health concerns.
Research shows it can protect esophageal tissue from acid damage and promote healing of esophageal lesions
Intestinal mucus barrier: a missing piece of the puzzle in food allergy